L

Leila Akkari

Oncode Institute

ORCID: 0000-0001-5479-641X

Publishes on Immune cells in cancer, Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers. 93 papers and 9.4k citations.

PubIndex Score99Top 1% · mid-careerHow it's scored

🌱#5 Emerging Leader in Liver physiology and pathology 🌱#8 Emerging Leader in Hepatitis B Virus Studies

93Publications

9.4kTotal Citations

#5in Liver physiology and pathology

First publication: 2010First senior author: 2019

Immune cells in cancer Glioma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers Cancer Cells and Metastasis Cancer, Hypoxia, and Metabolism

Top publicationsby citations

Single-cell spatial immune landscapes of primary and metastatic brain tumours

Elham Karimi, Logan A. Walsh, Morag Park et al.|Nature|2023

Cited by 397

Macrophage-mediated myelin recycling fuels brain cancer malignancy

Daan J. Kloosterman, Leila Akkari, Johanna Erbani et al.|Cell|2024

Cited by 189

Distinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix

Leila Akkari, Johanna A. Joyce|Genes & Development|2014

Cited by 116

Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer

Leila Akkari, Johanna A. Joyce|Genes & Development|2016

Cited by 63

Glioblastoma scRNA-seq shows treatment-induced, immune-dependent increase in mesenchymal cancer cells and structural variants in distal neural stem cells

Charles Couturier, Kevin Petrecca, Javad Nadaf et al.|Neuro-Oncology|2022

Cited by 59